awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36150601-24062807-72B7-4A89-9F74-C46DA0B42D75
Q36150601-24062807-72B7-4A89-9F74-C46DA0B42D75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36150601-24062807-72B7-4A89-9F74-C46DA0B42D75
Emerging anti-HIV drugs.
P2860
Q36150601-24062807-72B7-4A89-9F74-C46DA0B42D75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36150601-24062807-72B7-4A89-9F74-C46DA0B42D75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9bb8e6302547b3462b30dcc39adc3e147be1030c
P2860
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.